Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Heartbeam Inc (NQ: BEAT )

2.050 +0.010 (+0.49%)
Streaming Delayed Price Updated: 3:59 PM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,855
Open 2.070
Bid (Size) 2.050 (22)
Ask (Size) 2.170 (20)
Prev. Close 2.040
Today's Range 2.000 - 2.070
52wk Range 1.060 - 3.740
Shares Outstanding 34,260,799
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Presents Key Data in First-Ever Scientific Presentation of Proprietary HeartBeam AI
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias
From HeartBeam, Inc.
Via Business Wire

Performance

YTD
-12.02%
-12.02%
1 Month
-6.82%
-6.82%
3 Month
+19.88%
+19.88%
6 Month
+56.49%
+56.49%
1 Year
N/A
N/A

More News

Read More
Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
BEAT Stock Earnings: HeartBeam Meets EPS for Q4 2023
Via InvestorPlace
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Financial Results, Corporate Highlights for Q4, FY 2023
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Recap: HeartBeam Q4 Earnings
Via Benzinga
HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results
From HeartBeam, Inc.
Via Business Wire
Earnings Scheduled For March 20, 2024
Via Benzinga
A Preview Of HeartBeam's Earnings
Via Benzinga
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Enrolls First Patients in Key Study Assessing Proprietary AIMIGo(TM) System
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG
From HeartBeam, Inc.
Via Business Wire
What's Going On With Heartbeam (BEAT) Stock?
Via Benzinga
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Awarded Two New US Patents Covering Core Cardiac Monitoring Technology
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology
From HeartBeam, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q4 and FY 2023 Results Call
Via Investor Brand Network
HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Combines AI, Proprietary Technology to Deliver Unprecedented Cardiac Insights
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.